Furthermore, a subset of CTCs and tumor-initiating cells may exhibit dynamic changes in epithelial–mesenchymal transition phenotype (Yu et al., 2013), which can upregulate CD81 expression in mesenchymal breast cancer (Uretmen Kagiali et al., 2019). The gene discussed is CD81; the disease is breast cancer.